Tearsheet

Eureka Acquisition (EURK)

Market Price (10/31/2025): $10.81 | Market Cap: $20.5 Mil
Sector: Financials | Industry: Multi-Sector Holdings

Eureka Acquisition (EURK)

Market Price (10/31/2025): $10.81
Market Cap: $20.5 Mil
Sector: Financials
Industry: Multi-Sector Holdings

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.6%		Very low revenue Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
1			Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -0.8 Mil

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.6%
1	Very low revenue Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
2	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -0.8 Mil

Market Valuation & Key Metrics

Valuation
Key Metrics

null

	EURK	S&P 500
REVENUE GROWTH	FAIR
Rev LTM ($ Bil)	0.0
Rev Chg Q	�	6.4%
Rev Chg LTM	�	5.4%
VALUATION	LOW
P/CFO	-33.1	15.5
P/FCF	-33.1	20.6
P/E	12.2	23.6

EURK Stock

Return (1M):

Factor Drivers of Stock Movement

null

null

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
EURK Return	-	-	-	-	-	7%	-100%
Peers Return							0%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	110%
Monthly Win Rates [3]
EURK Win Rate	-	-	-	-	100%	-
Peers Win Rate						62%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
EURK Max Drawdown	-	-	-	-	-	-
Peers Max Drawdown
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: BCAR, AEXA, BACC, BRR, CCCX.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

EURK has limited trading history. Below is the Financials sector ETF (XLF) in its place.

Unique Key	Event	XLF	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-26.9%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	36.7%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	525 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-43.3%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	76.5%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	295 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-26.1%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	35.2%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	338 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-83.7%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	515.2%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	4470 days	1480 days

Compare to

In The Past

SPDR Select Sector Fund's stock fell -26.9% during the 2022 Inflation Shock from a high on 1/12/2022. A -26.9% loss requires a 36.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Eureka Acquisition (EURK)

Business Description

We were incorporated on June 13, 2023 as an exempted company with limited liability. We chose to incorporate in the Cayman Islands due to (i) its tax-neutrality, which allows international transactions to be structured efficiently without an additional layer of tax and (ii) simplicity of establishment and flexibility of administration, including easy migration to another jurisdiction, the existence of statutory procedures for merger or consolidation, and no takeover code or bespoke public company filing requirements. We were formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” We do not have any specific business combination under consideration and we have not (nor has anyone on our behalf), directly or indirectly, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location but will initially focus in Asia. We may consummate a business combination with an entity located in China (including Hong Kong and Macau). Further, due to the fact that certain of our executive officers and directors are located in or have significant ties to China, it may make us a less attractive partner to certain potential target businesses, including non-China-or non-Hong Kong-based target companies, and such perception may potentially limit or negatively impact our search for an initial business combination or may therefore make it more likely for us to consummate a business combination with a company based in or having the majority of its operations in the PRC and/or Hong Kong. Our management team has an extensive track record of creating value for shareholders by acquiring strong businesses at disciplined valuations, investing in growth while fostering financial discipline and ultimately improving financial results. Our team consists of experienced investment banking, financial services and capital market professionals and senior operating executives of companies in multiple jurisdictions. We believe we will benefit from their accomplishments, and specifically their current activities in the Asian market, in identifying attractive acquisition opportunities. We are a Cayman Islands exempted company incorporated on June 13, 2023. Our executive offices are located at Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman.

Better Bets than Eureka Acquisition (EURK)

	EURK	Better Performance than EURK
Metric	Value	Industry (Multi-Sector Holdings)
Total Yield	8.2%	VOYA (10.0%), GRAF (15.9%), MACI (12.2%)

	EURK	Better Performance than EURK
Metric	Value	Sector (Financials)
Total Yield	8.2%	WFC (9.3%), RY (9.3%), TD (14.9%), PGR (11.0%), CB (10.1%)

	EURK	Better Performance than EURK
Metric	Value	All Other Sectors
Total Yield	8.2%	XOM (9.7%), JNJ (8.2%), BABA (36.3%), TM (2018.7%), CVX (9.6%)

		Best Bets In Financials Sector
	EURK	DBRG	OTF	MTG	NMIH	CACC	ENVA	FNF	ACGL	APAM	FI
What You Pay
P/E	12.3	39.7	13.2	8.4	7.5	12.3	10.2	13.9	8.6	10.5	10.6
P/EBIT	-24.7	64.7	9.0	6.4	5.5	9.9	7.8	8.9	7.6	6.1	5.8
What You Get
Rev Chg Q	�	-102.4%	1,228.5%	-0.7%	7.2%	8.3%	16.3%	16.8%	22.4%	4.4%	8.0%
Rev Chg LTM	�	-84.8%	89.0%	2.2%	10.0%	12.5%	21.1%	7.4%	23.5%	10.0%	6.7%
Rev Chg 3Y Avg	�	125.8%	221.9%	1.2%	10.1%	6.9%	23.5%	-0.7%	29.8%	0.2%	7.5%
FCF/Rev 3Y Avg	�	101.2%	76.2%	62.2%	58.8%	57.1%	54.7%	50.8%	38.4%	29.0%	20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	How Low Can Eureka Acquisition Stock Really Go?	Return

	Title
0	ARTICLES
1	How Low Can Eureka Acquisition Stock Really Go?

Trade Ideas

Select past ideas related to EURK. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield	09302025	HLNE	Hamilton Lane	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-14.4%	-14.4%	-14.4%
CNS_9302025_Dip_Buyer_ValueBuy	09302025	CNS	Cohen & Steers	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper	09262025	JKHY	Jack Henry & Associates	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.3%	0.3%	-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	FDS	FactSet Research Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-7.7%	-7.7%	-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%	09052025	IBKR	Interactive Brokers	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	15.0%	15.0%	0.0%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield	09302025	HLNE	Hamilton Lane	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-14.4%	-14.4%	-14.4%
CNS_9302025_Dip_Buyer_ValueBuy	09302025	CNS	Cohen & Steers	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper	09262025	JKHY	Jack Henry & Associates	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.3%	0.3%	-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	FDS	FactSet Research Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-7.7%	-7.7%	-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%	09052025	IBKR	Interactive Brokers	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	15.0%	15.0%	0.0%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	279.1%	161.2%
2	INBX	Inhibrx Biosciences	131.0%	409.8%
3	PUMP	ProPetro	99.6%	16.2%
4	DYN	Dyne Therapeutics	88.4%	-0.0%
5	VICR	Vicor	85.4%	89.2%
6	CELC	Celcuity	74.6%	503.2%
7	GLUE	Monte Rosa Therapeutics	73.5%	87.5%
8	NVTS	Navitas Semiconductor	72.1%	251.8%
9	LUMN	Lumen Technologies	70.3%	94.7%
10	BALY	Ballys	63.4%	4.1%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	-62.9%	5106.3%
2	LRN	Stride	-53.8%	-35.8%
3	FMC	FMC	-51.0%	-66.6%
4	FI	Fiserv	-48.3%	-68.3%
5	NFE	New Fortress Energy	-43.6%	-91.9%
6	VG	Venture Global	-41.7%
7	OGN	Organon	-40.2%	-55.0%
8	VRNS	Varonis Systems	-39.5%	-21.2%
9	ITGR	Integer	-38.5%	-52.2%
10	LENZ	LENZ Therapeutics	-37.9%	5.5%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

Peer Comparisons for Eureka Acquisition

Financials

	EURK	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Eureka A.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
Mkt Price	-	10.05	11.48	10.06	10.21	17.86	10.21
Mkt Cap	0.0	-	-	-	-	-	0.0
Rev LTM	0	-	-	-	-	0	0
Op Inc LTM	-1	-	-	-	-	-0	-1
FCF LTM	-1	-	-	-	-	-1	-1
FCF 3Y Avg	-	-	-	-	-	-	-
CFO LTM	-1	-	-	-	-	-1	-1
CFO 3Y Avg	-	-	-	-	-	-	-

Growth & Margins

	EURK	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Eureka A.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
Rev Chg LTM	-	-	-	-	-	-	-
Rev Chg 3Y Avg	-	-	-	-	-	-	-
Rev Chg Q	-	-	-	-	-	-	-
QoQ Delta Rev Chg LTM	-	-	-	-	-	-	-
Op Mgn LTM	-	-	-	-	-	-	-
Op Mgn 3Y Avg	-	-	-	-	-	-	-
QoQ Delta Op Mgn LTM	-	-	-	-	-	-	-
CFO/Rev LTM	-	-	-	-	-	-	-
CFO/Rev 3Y Avg	-	-	-	-	-	-	-
FCF/Rev LTM	-	-	-	-	-	-	-
FCF/Rev 3Y Avg	-	-	-	-	-	-	-

Valuation

	EURK	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Eureka A.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
Mkt Cap	0.0	-	-	-	-	-	0.0
P/S	-	-	-	-	-	-	-
P/EBIT	-24.7	-	-	-	-	-	-24.7
P/E	12.3	-	-	-	-	-	12.3
P/CFO	-33.2	-	-	-	-	-	-33.2
Total Yield	8.2%	-	-	-	-	-	8.2%
Dividend Yield	0.0%	-	-	-	-	-	0.0%
FCF Yield 3Y Avg	-	-	-	-	-	-	-
D/E	0.0	-	-	-	-	-	0.0
Net D/E	-0.0	-	-	-	-	-	-0.0

Returns

	EURK	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Eureka A.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
1M Rtn	-	1.2%	5.0%	0.6%	0.9%	38.9%	1.2%
3M Rtn	-	-	-	-	-1.6%	76.0%	37.2%
6M Rtn	-	-	-	-	-	-	-
12M Rtn	-	-	-	-	-	-	-
3Y Rtn	-	-	-	-	-	-	-
1M Excs Rtn	-	-0.4%	3.5%	-1.1%	-0.8%	36.9%	-0.4%
3M Excs Rtn	-	-	-	-	-10.2%	66.8%	28.3%
6M Excs Rtn	-	-	-	-	-	-	-
12M Excs Rtn	-	-	-	-	-	-	-
3Y Excs Rtn	-	-	-	-	-	-	-

Financials

Annual
Quarterly

$ Mil \| FY: 9/30	LTM	2024
Period End	6/30/2025	9/30/2024
Filing Date	8/11/2025	12/26/2024
Key Financials
Total Revenue	0	0
Net Income	2	0
EPS	0.57	-0.34
Growth Rates
Total Revenue Growth	-	-
Net Income Growth	1511.1%	-
Margins
Net Income Margin	-	-
Cash & Debt
Total Cash	0	1
Total Debt	0	0
Net Debt / (Cash)	-0	-1
Cash Flows
Net Cash from Operations	-1	-0
Free Cash from Operations	-1	-0
Returns to Shareholders
Dividends	0	-0
Share Repurchases	-0	-0

$ Mil \| FY: 9/30	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023
Filing Date	8/11/2025	5/15/2025	2/12/2025	12/26/2024	8/14/2024	7/2/2024	3/8/2024	7/2/2024
Key Financials Quarterly
Total Revenue	0	0	0	0	0	0	0	0
Net Income	0	0	1	0	-0	-0	-0	-0
EPS	0.19	0.22	0.29	-0.12	-0.00	-0.00	-0.01	-0.00
Key Financials TTM
Total Revenue TTM	0	0	0	0	0	-	-	-
Net Income TTM	2	1	1	0	-0	-	-	-
Growth Rates Quarterly
Total Revenue Growth	-	-	-	-	-	-	-	-
Net Income Growth	1307.5%	1606.2%	1053.9%	7029.0%	-	-	-	-
Margins Quarterly
Net Income Margin	-	-	-	-	-	-	-	-
Cash & Debt
Total Cash	0	0	1	1	0	0	0	-
Total Debt	0	0	0	0	0	0	0	0
Net Debt / (Cash)	-0	-0	-1	-1	0	0	0	-
Cash Flows Quarterly
FCF from Operations	-0	-0	-0	-0	0	-0	-0	-0
Cash Flows TTM
FCF from Operations TTM	-1	-1	-0	-0	-0	-	-	-
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-3.3%	-1.3%	-1.0%	-1.7%	-34.9%	-40.5%	-94.3%	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	-2.7%	-1.0%	-0.8%	-0.6%	-35.3%	-	-	-

	1M	2M	3M	6M	1Y	3Y
Beta	-0.10	-0.10	-0.07	-0.01	-0.01	-0.01
Up Beta	-0.27	-0.02	-0.14	-0.02	-0.02	0.00
Down Beta	-0.03	-0.25	-0.26	-0.01	0.00	0.00
Up Capture	-1%	-3%	8%	3%	2%	0%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	4	6	13	34	63	67
Down Capture	-18%	-18%	-11%	-5%	-5%	-3%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	2	4	6	21	36	38

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	209
Short Interest: % Change Since 9302025	0.0%
Average Daily Volume	1,363
Days-to-Cover Short Interest	1
Basic Shares Quantity	1,895,500
Short % of Basic Shares	0.0%

Returns Analyses

	Title
0	How Low Can Eureka Acquisition Stock Really Go?

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8112025	10-Q 6/30/2025
3312025	5152025	10-Q 3/31/2025
12312024	2122025	10-Q 12/31/2024
9302024	12262024	10-K 9/30/2024
6302024	8142024	10-Q 6/30/2024
3312024	7022024	424B4 3/31/2024
12312023	3082024	S-1 12/31/2023

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	MIZUHO SECURITIES USA LLC		7152025	Sell	10.55	40,560	427,746	3,971,170	Form

Industry Resources

Financials Resources

Federal Reserve Economic Data

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Eureka Acquisition (EURK)

Market Price (10/31/2025): $10.81 | Market Cap: $20.5 MilSector: Financials | Industry: Multi-Sector Holdings

Eureka Acquisition (EURK)

Market Price (10/31/2025): $10.81Market Cap: $20.5 MilSector: FinancialsIndustry: Multi-Sector Holdings

Market Valuation & Key Metrics

EURK Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Eureka Acquisition (EURK)

Interactive Breakdown

Better Bets than Eureka Acquisition (EURK)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Eureka Acquisition

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/31/2025): $10.81 | Market Cap: $20.5 Mil
Sector: Financials | Industry: Multi-Sector Holdings

Market Price (10/31/2025): $10.81
Market Cap: $20.5 Mil
Sector: Financials
Industry: Multi-Sector Holdings